MedTrace Logo

The Study of AZD8529 for Smoking Cessation in Female Smokers

NCT02401022 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2017-11-29

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy and safety of AZD8529 for smoking cessation in female smokers.

Conditions

  • Tobacco Use Disorder

Interventions

DRUG

AZD8529

comparison of different dosages of drug

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Shwe Gyaw, MD · National Institute on Drug Abuse (NIDA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-11-30
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02401022 on ClinicalTrials.gov